Cite
HARVARD Citation
Thompson, P. et al. (2018). Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL). Expert opinion on investigational drugs. pp. 31-42. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Thompson, P. et al. (2018). Bruton's tyrosine kinase inhibitors: first and second generation agents for patients with Chronic Lymphocytic Leukemia (CLL). Expert opinion on investigational drugs. pp. 31-42. [Online].